NICE In Brief
This article was originally published in The Gray Sheet
The U.K.’s National Institute for Health and Care Excellence OK’s subcutaneous ICD implantation, but recommends outcomes data collection. Vertebroplasty and kyphoplasty win recommendation in technology appraisal guidance. More news from NICE.
You may also be interested in...
NICE changes name, leader, and expands mission to social care. Cordis wins Cypher patent case on appeal. More news in brief.
St. Jude Medical’s Genesis for chronic migraine
Ten years ago, the ICD market was booming, now it's not, despite studies that show the device is underutilized. The increasing complexity of CRM devices, and in particular ICDs, has brought a host of problems - including major product recalls that in turn have created caution on the part of patients - and has done little to grow the market beyond single digits in recent years. Cameron Health believes it has the answer for a truly disruptive ICD with a contrarian twist: a simpler device that addresses major problems such as lead failures, inappropriate shocks, and the burdens of complexity.